Literature DB >> 1381315

Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels.

H Heremans1, C Dillen, W Put, J Van Damme, A Billiau.   

Abstract

Two rat monoclonal antibodies (6B4 and 20F3) against mouse interleukin (IL)-6 were studied for their effects on the generalized Shwartzman reaction and on cytokine production elicited by endotoxin injections. Both antibodies were found to protect mice against the generalized Shwartzman reaction. Production of interferon and tumor necrosis factor in these animals, as assessed from serum levels, were not consistently affected by the antibody treatment, although rather increased levels were occasionally noted. Paradoxically, however, endotoxin-induced serum levels of IL-6 in anti-IL-6-treated mice were consistently found to be markedly increased and also to persist for longer time periods. The more vigorous and persistent response may have been due to slower elimination, increased synthesis, or a combination of both. Endogenous production of IL-6 in mice may be sufficiently large to supersede the neutralizing potential of an excess of antibody, as was evident from the fact that ascites fluid of the anti-IL-6-producing 6B4 hybridoma was biologically active in the IL-6 assay.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381315     DOI: 10.1002/eji.1830220932

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

1.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

Authors:  Z Xing; J Gauldie; G Cox; H Baumann; M Jordana; X F Lei; M K Achong
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

2.  The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics.

Authors:  Siva Charan Devanaboyina; Sandra M Lynch; Raimund J Ober; Sripad Ram; Dongyoung Kim; Alberto Puig-Canto; Shannon Breen; Srinath Kasturirangan; Susan Fowler; Li Peng; Haihong Zhong; Lutz Jermutus; Herren Wu; Carl Webster; E Sally Ward; Changshou Gao
Journal:  MAbs       Date:  2013 Nov-Dec       Impact factor: 5.857

Review 3.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine.

Authors:  I S Leal; B Smedegârd; P Andersen; R Appelberg
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses.

Authors:  C Truyens; A Angelo-Barrios; F Torrico; J Van Damme; H Heremans; Y Carlier
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.

Authors:  B Ryffel; B D Car; H Gunn; D Roman; P Hiestand; M J Mihatsch
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

7.  Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop.

Authors:  H C van Zaanen; R P Koopmans; L A Aarden; H J Rensink; J M Stouthard; S O Warnaar; H M Lokhorst; M H van Oers
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice.

Authors:  A Nakane; M Okamoto; M Asano; M Kohanawa; T Minagawa
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice.

Authors:  P Matthys; T Mitera; H Heremans; J Van Damme; A Billiau
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Trp53 deficiency protects against acute intestinal inflammation.

Authors:  Martina E Spehlmann; Carolin F Manthey; Sara M Dann; Elaine Hanson; Sukhman S Sandhu; Linus Y Liu; Farid K Abdelmalak; Michaela A Diamanti; Kristin Retzlaff; Jürgen Scheller; Stefan Rose-John; Florian R Greten; Jean Y J Wang; Lars Eckmann
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.